UBS Group’s Renalytix plc American Depositary Shares RNLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-279,743
| Closed | -$58.5K | – | 10751 |
|
|
2024
Q3 | $58.5K | Buy |
279,743
+279,668
| +372,891% | +$89.4K | ﹤0.01% | 6716 |
|
|
2024
Q2 | $17 | Buy |
+75
| New | +$45 | ﹤0.01% | 9324 |
|
|
2023
Q4 | – | Sell |
-4,061
| Closed | -$6.5K | – | 10138 |
|
|
2023
Q3 | $6.5K | Sell |
4,061
-2,349
| -37% | -$6.49K | ﹤0.01% | 7297 |
|
|
2023
Q2 | $18.7K | Buy |
6,410
+6,177
| +2,651% | +$14K | ﹤0.01% | 6908 |
|
|
2023
Q1 | $564 | Sell |
233
-7,727
| -97% | -$21.4K | ﹤0.01% | 8973 |
|
|
2022
Q4 | $14.9K | Buy |
7,960
+6,460
| +431% | +$10.1K | ﹤0.01% | 8036 |
|
|
2022
Q3 | $2K | Buy |
1,500
+1,000
| +200% | +$2.18K | ﹤0.01% | 9814 |
|
|
2022
Q2 | $1K | Sell |
500
-100
| -17% | -$476 | ﹤0.01% | 10035 |
|
|
2022
Q1 | $4K | Sell |
600
-2,543
| -81% | -$26.9K | ﹤0.01% | 9345 |
|
|
2021
Q4 | $50K | Buy |
3,143
+1,643
| +110% | +$32.9K | ﹤0.01% | 6898 |
|
|
2021
Q3 | $30K | Sell |
1,500
-4,100
| -73% | -$106K | ﹤0.01% | 6765 |
|
|
2021
Q2 | $173K | Buy |
5,600
+3,600
| +180% | +$108K | ﹤0.01% | 5465 |
|
|
2021
Q1 | $51K | Buy |
2,000
+1,341
| +203% | +$33.6K | ﹤0.01% | 6531 |
|
|
2020
Q4 | $11K | Buy |
+659
| New | +$8.13K | ﹤0.01% | 7439 |
|